Liang P

No ORCID on file · 5 papers in corpus · active 2020-2026

Study types

  • article 1
  • other 1

Condition tags

  • endometriosis 1
  • adenomyosis 1
other 2026
Reduced type 2 epithelial-mesenchymal transition serves as a risk factor for the progression from endometriosis to endometriosis-associated ovarian cancer
Scientific reports ·doi:10.1038/s41598-026-51155-0

Endometriosis-associated ovarian cancer (EAOC) is a rare subtype of ovarian cancer arising from the malignant transformation of endometriosis (EMS). Despite growing clinical awareness, its underlying pathogenic mechanisms are not fully unde…

2026
Transrectal biplane ultrasound-guided transperineal biopsy for rectal and peri-rectal lesions: an 18-year retrospective analysis.
Quantitative Imaging in Medicine and Surgery ·doi:10.21037/qims-2025-1691

BackgroundAccurate diagnosis of rectal and perirectal lesions remains challenging, particularly for submucosal, necrotic, or anatomically complex masses where conventional endoscopic forceps biopsy (EFB) often yields insufficient tissue. Tr…

2026
Ultrasound-guided percutaneous microwave ablation assisted by a three-dimensional visualization treatment platform (3DVOPS) for large uterine fibroids.
Abdominal radiology (New York) ·doi:10.1007/s00261-025-05024-5

BackgroundThis study aims to evaluate the efficacy of a three-dimensional visualization operative planning system (3DVOPS) in ultrasound-guided percutaneous microwave ablation (US-PMWA) for the treatment of large uterine fibroids.MethodsFro…

2021
Cause Analysis and Diagnosis and Treatment of Intestinal Fistulas After Ultrasound-Guided Microwave Ablation of Abdominopelvic Lesions.
Frontiers in surgery ·doi:10.3389/fsurg.2021.675585

Objective: To determine the cause and high-risk factors for the development of intestinal fistulas (IFs) after ultrasound-guided microwave ablation (MA) of abdominopelvic lesions, and to identify effective prophylactic and therapeutic actio…

article 2020
Comparison between microwave ablation and radiofrequency ablation for treating symptomatic uterine adenomyosis
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group ·doi:10.1080/02656736.2019.1708481

The safety and effectiveness of PMWA and USgRFA in the treatment of uterine adenomyosis were similar; however, the mean ablation time of PMWA was shorter than that of USgRFA.